Fibrosis is a common denominator and an important determinant of outcomes in chronic kidney disease (CKD). Extracellular matrix deposition is a specific and potentially useful biomarker to identify scarred kidneys. Magnetization transfer imaging (MTI) is a powerful noninvasive technique based on molecular magnetic resonance imaging (MRI), which is capable of detecting excessive collagen deposition. Therefore, MTI could be invaluable to assess individual kidneys, yet its potential to detect renal fibrosis has no been fully explored. Renal vascular disease (RVD), which is becoming increasingly common in the aging population of the Western world, may induce kidney ischemia and fibrosis. As a result of permanent injury, revascularization of the stenotic renal artery by percutaneous transluminal renal angioplasty (PTRA) often fails to restore kidney function and arrest progression of CKD. We have shown that failure to restore renal function after PTRA in RVD is directly linked with the extent of intra-renal injury. Alas, specific tools to detect renal fibrosis and adequately predct renal outcomes in RVD are yet to be identified and remain in dire need. We have characterized novel experimental models of RVD that closely mimic human pathophysiology and allow translational studies relevant to clinical medicine. We have also developed and refined unique imaging techniques ideally suited for probing renal adaptive processes. These tools now provide an opportunity to assess renal function and structure associated with development of fibrosis and outcomes in RVD. The working hypothesis underlying this proposal is that MTI can detect in the post-stenotic murine and swine kidneys development of fibrosis, which correlates with subsequent kidney recovery capacity. To test this hypothesis, we will study development and progression of stenotic kidney fibrosis, dysfunction, and hypoxia using cutting-edge noninvasive imaging. Furthermore, the ability of MTI-derived indices of collagen deposition to predict renal recovery will be tested in RVD pigs undergoing PTRA and stenting.
Three specific aims will be pursued:
Specific Aim 1 will test the hypothesis that MTI can detect development of kidney fibrosis in RAS mice using high-field MRI.
Specific Aim 2 will test the hypothesis that MTI can detect development of renal fibrosis using a clinical MRI in RVD pigs.
Specific Aim 3 will test the hypothesis that MTI would predict renal recovery potential in response to PTRA. Noninvasive assessment of extracellular matrix deposition using MTI is a promising, cutting edge technique, which will likely contribute significantly towards management of kidney disease. The proposed studies may have broad ramifications and establish this novel, clinically feasible diagnostic strategy for RVD and CKD.

Public Health Relevance

Adequate strategies to detect fibrosis and remodeling within the kidney in chronic kidney disease are yet to be identified and remain in dire need. Magnetization transfer imaging (MTI) is a novel non-invasive experimental strategy that can detect scar tissue, but is yet to be tested in the kidney. The proposed studies may establish this clinically feasible diagnostic strategy and will likely contribute significantly towards management of patients with chronic kidney disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01DK104273-02S1
Application #
9134408
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O5))
Program Officer
Rys-Sikora, Krystyna E
Project Start
2014-09-24
Project End
2019-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
2
Fiscal Year
2015
Total Cost
$5,072
Indirect Cost
$1,882
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Jiang, Kai; Tang, Hui; Mishra, Prasanna K et al. (2018) Measurement of Murine Single-Kidney Glomerular Filtration Rate Using Dynamic Contrast-Enhanced MRI. Magn Reson Med 79:2935-2943
Conley, Sabena M; Zhu, Xiang-Yang; Eirin, Alfonso et al. (2018) Metabolic syndrome alters expression of insulin signaling-related genes in swine mesenchymal stem cells. Gene 644:101-106
Jiang, Kai; Tang, Hui; Mishra, Prasanna K et al. (2018) A rapid T1 mapping method for assessment of murine kidney viability using dynamic manganese-enhanced magnetic resonance imaging. Magn Reson Med 80:190-199
Zhu, Xiang-Yang; Zou, Xiangyu; Mukherjee, Rahul et al. (2018) Targeted Imaging of Renal Fibrosis Using Antibody-Conjugated Gold Nanoparticles in Renal Artery Stenosis. Invest Radiol 53:623-628
Hedayat, Ahmad F; Park, Kyoung-Ha; Kwon, Taek-Geun et al. (2018) Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model. Transl Res 192:30-45
Zhang, Xin; Kim, Seo Rin; Ferguson, Christopher M et al. (2018) The Metabolic Syndrome Does Not Affect Development of Collateral Circulation in the Poststenotic Swine Kidney. Am J Hypertens 31:1307-1316
Eirin, Alfonso; Hedayat, Ahmad F; Ferguson, Christopher M et al. (2018) Mitoprotection preserves the renal vasculature in porcine metabolic syndrome. Exp Physiol 103:1020-1029
Zou, Xiangyu; Kwon, Soon Hyo; Jiang, Kai et al. (2018) Renal scattered tubular-like cells confer protective effects in the stenotic murine kidney mediated by release of extracellular vesicles. Sci Rep 8:1263
Zou, Xiangyu; Jiang, Kai; Puranik, Amrutesh S et al. (2018) Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury. Stem Cells Transl Med 7:394-403
Meng, Yu; Eirin, Alfonso; Zhu, Xiang-Yang et al. (2018) Obesity-induced mitochondrial dysfunction in porcine adipose tissue-derived mesenchymal stem cells. J Cell Physiol 233:5926-5936

Showing the most recent 10 out of 61 publications